Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Stephen Bagley(Translational Therapeutics (United States)), Meghan Logun(University of Pennsylvania), Joseph A. Fraietta(University of Pennsylvania), Xin Wang(University of Pennsylvania), Arati Desai(University of Pennsylvania), Linda J. Bagley(University of Pennsylvania), Ali Nabavizadeh(University of Pennsylvania), Danuta Jarocha(University of Pennsylvania), Rene Martins(University of Pennsylvania), Eileen Maloney(University of Pennsylvania), Lester Lledo(University of Pennsylvania), Carly Stein(University of Pennsylvania), Amy Marshall(University of Pennsylvania), Rachel Leskowitz(University of Pennsylvania), Julie K. Jadlowsky(University of Pennsylvania), Shannon Christensen(University of Pennsylvania), Bike Su Oner(University of Pennsylvania), Gabriela Plesa(University of Pennsylvania), Andrea Brennan(University of Pennsylvania), Vanessa Gonzalez(University of Pennsylvania), Fang Chen(University of Pennsylvania), Yusha Sun(University of Pennsylvania), Whitney L. Gladney(Kite (United States)), David M. Barrett(Kite (United States)), MacLean P. Nasrallah(University of Pennsylvania), Wei‐Ting Hwang(University of Pennsylvania), Guo‐li Ming(California Institute for Regenerative Medicine), Hongjun Song(California Institute for Regenerative Medicine), Donald L. Siegel(University of Pennsylvania), Carl H. June(University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Zev A. Binder(University of Pennsylvania), Donald M. O’Rourke(Translational Therapeutics (United States))
Cited by 321Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis